🇺🇸 FDA
Patent

US 7138237

Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen

granted A61PA61P1/04

Quick answer

US patent 7138237 (Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen) held by The Regents of the University of California expires Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Nov 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/04